Prostaglandin E{HD 2 {B and derivatives for reducing the side effects of anti-inflammatory agents

A method is disclosed for inhibiting and alleviating gastrointestinal side effects often encountered during therapy with antiinflammatory agents such as indomethacin, phenylbutazone, oxyphenylbutazone and the like. The method comprises the administration of prostaglandin E2, 15-methylprostaglandin E...

Full description

Saved in:
Bibliographic Details
Main Author LIPPMANN; WILBUR
Format Patent
LanguageEnglish
Published 16.12.1975
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A method is disclosed for inhibiting and alleviating gastrointestinal side effects often encountered during therapy with antiinflammatory agents such as indomethacin, phenylbutazone, oxyphenylbutazone and the like. The method comprises the administration of prostaglandin E2, 15-methylprostaglandin E2, 16-methylprostaglandin E2 or 16,16-dimethylprostaglandin E2 or their corresponding lower alkyl esters to a mammal receiving such therapy.
Bibliography:Application Number: US19730378113